Difference between revisions of "Part:BBa K364307:Experience"
(→References) |
(→Ligand) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 2: | Line 2: | ||
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | ||
how you used this part and how it worked out. | how you used this part and how it worked out. | ||
| + | |||
| + | |||
===Physiological effects of ER=== | ===Physiological effects of ER=== | ||
Latest revision as of 01:53, 26 October 2010
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Physiological effects of ER
In the absence of hormone, estrogen receptors are largely located in the cytosol. Hormone binding to the receptor triggers a number of events starting with migration of the receptor from the cytosol into the nucleus, dimerization of the receptor, and subsequent binding of the receptor dimer to specific sequences of DNA. Some of the effects in humans: Createing proliferative endometrium,breast cell stimulation, increased body fat and weight gain, salt and fluid retention, increased risk of blood clots.
Potential applications of ER DBD
ER-DBD can be fused with various LBDs in order to get heterogenous composite Nuclear Receptors. With addition of the LBD's ligand the receptor can bind to Estrogen Receptor Response element and activate downstream gene expression.
Applications of BBa_K364307
User Reviews
UNIQ843be55cdeb3774b-partinfo-00000000-QINU UNIQ843be55cdeb3774b-partinfo-00000001-QINU